6 Results for "

OCI-Ly3

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "OCI-Ly3" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-15970
CAS No.: 1392136-43-4
Synonyms: KPT-335
Target:  

CRM1 Apoptosis RSV

Verdinexor (KPT-335) is an orally active inhibitor for selective inhibitor of nuclear export (SINE). Verdinexor inhibits the respiratory syncytial virus A2 (RSV A2) replication with an IC50 of 0.96 µM. Verdinexor inhibits the function of nuclear export protein Exportin 1 (XPO1/CRM1), inhibiting pro-inflammatory responses. Verdinexor exhibits antitumor effciency .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-142648
CAS No.: 1832576-25-6
Purity:  99.49%
Target:  

MALT1

Research Areas:  

Cancer

MLT-985 is a selective allosteric and orally active MALT1 inhibitor with an IC50 value of 3 nM. MLT-985 can suppress cell growth and aberrant CARD11/BCL10/MALT1 complex signaling. MLT-985 can be used for the research of cancer, such as B cell malignancies .
loading...
    loading...
Cat. No.: HY-143422
CAS No.: 2504229-63-2
Target:  

MALT1

Research Areas:  

Cancer

MALT1-IN-3 (compound 122) is a potent MALT1 protease inhibitor, with an IC50 of 0.06 μM. MALT1-IN-3 has IC50 of 0.14 and 0.13 μM for human IL6/IL10 in OCI-LY3 cells, respectively .
loading...
    loading...
Cat. No.: HY-143422A
CAS No.: 2504229-61-0
Target:  

MALT1

Research Areas:  

Cancer

(R)-MALT1-IN-3 (compound 121) is a potent MALT1 protease inhibitor with an IC50 of 20 nM. (R)-MALT1-IN-3 has IC50 of 60 nM, 40 nM for human IL6/IL10 in OCI-LY3 cells, respectively .
loading...
    loading...
Cat. No.: HY-143426
CAS No.: 2244109-29-1
Target:  

MALT1

Research Areas:  

Cancer

MALT1-IN-8 is a potent MALT1 protease inhibitor with a IC50 of 2 nM. MALT1-IN-8 inhibits the growth of OCI-LY3 lymphoma cells with an IC50 of 1.16 μM. MALT1-IN-8 has anticancer effects (WO2018165385A1; Compound 8) .
loading...
    loading...
Cat. No.: HY-142648A
CAS No.: 1832577-07-7
Target:  

MALT1

Research Areas:  

Cancer

(R)-MLT-985 is the R configuration of MLT-985 (HY-142648). MLT-985 is a selective allosteric and orally active MALT1 inhibitor with an IC50 value of 3 nM. MLT-985 can suppress cell growth and aberrant CARD11/BCL10/MALT1 complex signaling. MLT-985 can be used for the research of cancer, such as B cell malignancies .
loading...
    loading...